EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrating Ultrabright Polymer Dots and Stereo NIR‐II Imager for Assessing Anti‐Angiogenic Drugs in Oral Cancer Model

Bo-Han Huang, Fang-Yu Li, Shih-Po Su, Chiung-Tong Chen, Kuo-Wei Chang, Muh-Hwa Yang, Min-Chieh Chen, Huihua Kenny Chiang, Yang-Hsiang Chan, Yi-Jang Lee iD

Journal of Cellular and Molecular Medicine · 2025

DOI: 10.1111/jcmm.70324 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Bo-Han Huang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Imaging and Radiological Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan. Hauptthemen laut MEDLINE: Angiogenesis Inhibitors, Mouth Neoplasms, Polymers, Neovascularization, Pathologic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council, Taiwan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The development of efficient platforms for the evaluation of anti‐angiogenic agents is critical in advancing cancer therapeutics. In this study, we exploited an ultrabright semiconducting polymer dots (Pdots) integrating with a three‐dimensional (3D) near‐infrared‐II (NIR‐II) fluorescence imaging system designed to assess the efficacy of potent anti‐angiogenic agents PX‐478 and BPR0C261 in an oral squamous cell carcinoma (OSCC) tumour model, which depends on angiogenesis for dissemination. PX‐478, a hypoxia‐inducible factor‐1α (HIF‐1α) inhibitor, and BPR0C261, a microtubule‐disrupting agent, were administrated into tumour‐bearing mice established using murine MTCQ1 tongue cancer cells through intraperitoneal injection and oral gavage, respectively. Our findings showed that PX‐478 and BPR0C261 significantly inhibited tumour growth and extended the life span of tumour‐bearing mice without decreasing the body weights. The Pdots‐based NIR‐II vascular imaging demonstrated that the tumour vascularity was suppressed by PX‐478 and BPRC0261. Accordingly, the excised tumours treated with anti‐angiogenic agents showed less blood vessels than that treated with vehicles. The expression of endothelial markers CD31 was also found to be reduced in tumours treated with PX‐478 and BPRC0261 using immunohistochemical (IHC) staining and Western blot analysis. Furthermore, PX‐478 could suppress the expression of HIF‐1α and vascular endothelial growth factor‐A (VEGF‐A), but BPRC0261 only suppressed VEGF‐A. Taken together, this innovative 3D NIR‐II imaging system combining the biocompatible Pdots with unique optical specificity enables non‐invasive, real‐time monitoring the efficacy of anti‐angiogenic compounds.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Angiogenesis InhibitorsMouth NeoplasmsPolymersNeovascularization, PathologicAnimalsMiceCell Line, TumorHypoxia-Inducible Factor 1, alpha SubunitOptical ImagingVascular Endothelial Growth Factor AHumansDisease Models, AnimalCarcinoma, Squamous CellMice, Inbred BALB CStilbenes

Stichwörter der Autor:innen

3D NIR‐II fluorescence imaging systemBPR0C261HIF‐1αanti‐angiogenic agentspolymer dotstumour vascularity

Substanzen

Angiogenesis InhibitorsPolymersHypoxia-Inducible Factor 1, alpha SubunitVascular Endothelial Growth Factor AfosbretabulinStilbenes

Autor:innen und Institutionen

  • Department of Biomedical Imaging and Radiological Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Department of Biomedical Engineering, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Zhunan, Taiwan.
  • Department of Dentistry, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Cancer and Immunology Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan.

ORCID-Profile: Yi-Jang Lee

Förderung

  • National Science and Technology Council, Taiwan

Zitieren

APA

Huang, B. H., Li, F. Y., Su, S. P., Chen, C. T., Chang, K. W., Yang, M. H., Chen, M. C., Chiang, H. K., Chan, Y. H., & Lee, Y. J. (2025). Integrating Ultrabright Polymer Dots and Stereo NIR‐II Imager for Assessing Anti‐Angiogenic Drugs in Oral Cancer Model. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70324

Vancouver

Huang BH, Li FY, Su SP, Chen CT, Chang KW, Yang MH, et al. Integrating Ultrabright Polymer Dots and Stereo NIR‐II Imager for Assessing Anti‐Angiogenic Drugs in Oral Cancer Model. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70324

BibTeX
@article{Huang2025,
  author = {Huang, Bo-Han and Li, Fang-Yu and Su, Shih-Po and Chen, Chiung-Tong and Chang, Kuo-Wei and Yang, Muh-Hwa and Chen, Min-Chieh and Chiang, Huihua Kenny and Chan, Yang-Hsiang and Lee, Yi-Jang},
  title = {Integrating Ultrabright Polymer Dots and Stereo NIR‐II Imager for Assessing Anti‐Angiogenic Drugs in Oral Cancer Model},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2025},
  doi = {10.1111/jcmm.70324}
}
Kostenlos starten →